Yuan Yuan Zhu
Algemeen Directeur bij BIOMICS BIOPHARMA LTD
Profiel
Yuan Yuan Zhu is the founder of NT Omics, Inc. (founded in 2005) and Biomics Biotechnologies Co., Ltd.
(founded in 2006), where he holds the title of Chairman & Chief Executive Officer.
Currently, he is the Executive Chairman, Chief Executive Officer & MD at Biomics Biopharma Ltd.
He also holds the position of Head-RNAi Technology Institution at Nantong University and Joint Professor at China Pharmaceutical University.
In his former positions, he worked as a Manager-Research & Development at Takara Bio USA, Inc., Chief Technology Officer at Reliance Genemedix Ltd.
(United Kingdom), Principal at The Memorial Foundation, Inc., and Chief Scientist at Zytogene, Inc. Dr. Zhu completed his graduate degree at Nantong University in 1985 and obtained his doctorate degree from Nagoya University in 1993.
Actieve functies van Yuan Yuan Zhu
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMICS BIOPHARMA LTD | Algemeen Directeur | - |
Biomics Biotechnologies Co., Ltd.
 Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Algemeen Directeur | - |
| China Pharmaceutical University | Corporate Officer/Principal | - |
| Nantong University | Corporate Officer/Principal | - |
Eerdere bekende functies van Yuan Yuan Zhu
| Bedrijven | Functie | Einde |
|---|---|---|
| NT Omics, Inc. | Oprichter | - |
| Zytogene, Inc. | Hoofd Techniek/Wetenschap/O&O | - |
Takara Bio USA, Inc.
 Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Hoofd Techniek/Wetenschap/O&O | - |
| Reliance Genemedix Ltd. (United Kingdom) | Hoofd Techniek/Wetenschap/O&O | - |
| The Memorial Foundation, Inc. | Corporate Officer/Principal | - |
Opleiding van Yuan Yuan Zhu
| Nantong University | Graduate Degree |
| Nagoya University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOMICS BIOPHARMA LTD | Process Industries |
| Bedrijven in privébezit | 6 |
|---|---|
Takara Bio USA, Inc.
Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Health Services |
| Reliance Genemedix Ltd. (United Kingdom) | Health Technology |
| The Memorial Foundation, Inc. | |
Biomics Biotechnologies Co., Ltd.
Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Health Technology |
| Zytogene, Inc. | |
| NT Omics, Inc. |